Indoco Company Profile
✉ Email this page to a colleague
What is the competitive landscape for INDOCO, and what generic and branded alternatives to INDOCO drugs are available?
INDOCO has fourteen approved drugs.
There is one tentative approval on INDOCO drugs.
Drugs and US Patents for Indoco
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Indoco | FEBUXOSTAT | febuxostat | TABLET;ORAL | 210292-001 | Dec 30, 2019 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Indoco | DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE | dorzolamide hydrochloride; timolol maleate | SOLUTION/DROPS;OPHTHALMIC | 202054-001 | Sep 3, 2014 | AT1 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Indoco | OLANZAPINE | olanzapine | TABLET;ORAL | 206155-003 | Jul 31, 2020 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.